Vanda Pharmaceuticals reported $66.93M in Cash and Equivalent for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Acadia Pharmaceuticals ACAD:US $ 204.92M 57.48M
Acorda Therapeutics ACOR:US $ 31.87M 13.76M
Agios Pharmaceuticals AGIO:US $ 80.03M 123.1M
Akebia Therapeutics AKBA:US $ 174.56M 24.76M
Alnylam Pharmaceuticals ALNY:US $ 534.08M 285.89M
Anika Therapeutics ANIK:US $ 90.32M 4.06M
Arrowhead Research ARWR:US $ 86.41M 5.18M
AstraZeneca AZN:LN 5762M 567M
Bluebird Bio BLUE:US $ 106.26M 54.9M
Bristol Myers Squibb BMY:US $ 12369M 1610M
Clovis Oncology CLVS:US $ 122.24M 21.19M
Eli Lilly And LLY:US $ 2459.2M 1359.3M
Enanta Pharmaceuticals ENTA:US $ 40.99M 58.08M
Esperion Therapeutics ESPR:US $ 150.36M 58.53M
Halozyme Therapeutics HALO:US $ 117.84M 0.88M
Heron Therapeutics HRTX:US $ 56.91M 33.63M
Insmed INSM:US $ 515.7M 201.08M
Intercept Pharmaceuticals ICPT:US $ 48.32M 36.39M
Lexicon Pharmaceuticals LXRX:US $ 59.52M 4.54M
Ligand Pharmaceuticals LGND:US $ 14.99M 4.53M
Merk MRK:US $ 8556M 460M
Minerva Neurosciences NERV:US $ 54.95M 5.81M
Moderna Inc MRNA:US 5.05B 1.8B
Novartis NVS:US $ 13852M 1445M
Sangamo Biosciences SGMO:US $ 120.26M 58.62M
Takeda 4502:JP Y 849695M 125354M
Teva Pharmaceutical TEVA:IT 2.18B 10M
Ultragenyx Pharmaceutical RARE:US $ 153.99M 153.6M
Vanda Pharmaceuticals VNDA:US $ 66.93M 14.86M
Veracyte VCYT:US $ 163.62M 9.58M